Ignite Creation Date:
2025-12-24 @ 11:47 PM
Ignite Modification Date:
2025-12-25 @ 9:41 PM
Study NCT ID:
NCT01855451
Status:
UNKNOWN
Last Update Posted:
2022-11-18
First Post:
2013-05-13
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Weekly Cetuximab/RT Versus Weekly Cisplatin/RT in HPV-Associated Oropharyngeal Squamous Cell Carcinoma
Sponsor:
Trans Tasman Radiation Oncology Group
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
TROG 12.01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None